Introduction
For anesthetic management of cesarean section, re gardless of the use of regional or general anesthesia, it is crucial to achieve suffi cient uterine contraction im mediately after the delivery of an infant to reduce excessive bleeding. For this purpose, oxytocin has been routinely used [1, 2] ; however, it is well known that volatile anesthetics cause myometrial relaxation and reduce the sensitivity to oxytocin. Often, the conventional use of oxytocin does not achieve suffi cient uterine contraction under the effect of volatile anesthetics. Therefore, in the case of general anesthesia using volatile anesthetics, two strategies have been recommended. One is reducing the concentration of the volatile anesthetic to the lowest possible level, and the other is shifting the volatile anesthetic to an intravenous anesthetic after the delivery of the infant [1, 2] . However, these procedures have been reported to increase the risk of intraoperative awareness in patients [3] . Therefore, an alternative uterotonic agent to inhibit the myometrial relaxation induced by volatile anesthetics is required.
Alprostadil is a synthesized prostaglandin that induces vascular dilation. In Japan, it is widely administered intravenously to treat critical hypertension and to induce deliberate hypotension during operations [4] [5] [6] . Alprostadil, like other prostaglandins, possesses a uterotonic effect and is thought by some practitioners to be effective in inducing uterine contractions without increasing blood pressure during cesarean sections [5] [6] [7] [8] . Several clinical reports have shown a decrease in blood loss during operations in conjunction with the use of alprostadil [5, 6] . Multiple case reports have shown the successful use of alprostadil during cesarean sections [7, 8] , but none have investigated the ability of alprostadil to inhibit myometrial relaxation induced by volatile anesthetics. The aim of the present study was to investigate the inhibitory effects of alprostadil on Abstract Purpose. For anesthetic management of cesarean sections, regardless of the use of regional or general anesthesia, it is crucial to achieve suffi cient uterine contraction immediately following the delivery of an infant in order to reduce excessive bleeding. No previous study has investigated the ability of alprostadil, a synthesized prostaglandin, to inhibit myometrial relaxation induced by volatile anesthetics. The aim of the present study was to investigate the inhibitory effects of alprostadil on sevofl urane-induced myometrial relaxation using myometrial strips isolated from pregnant rats. Methods. Myometrial strips were isolated from SpragueDawley rats (300-400 g) in the late stage of gestation (19-21 days). The time course of changes in spontaneous myometrium contraction was studied in the presence and absence of sevofl urane. Additionally, alprostadil was titrated at three different concentrations during continuous introduction of sevofl urane 2%, and myometrium contraction was studied. As an index of contraction, the area under the contraction curve was used, and data were analyzed by repeated measure one-way analysis of variance. Results. We have shown a signifi cant decrease in myometrium contraction as a result of the use of sevofl urane (2%). Additionally, alprostadil has been shown to inhibit myometrial relaxation induced by sevofl urane in a dose-dependent manner. The areas under the contraction curve were 87%, 87%, 129%, and 172% of the baseline value for the control and at low, medium, and high concentrations of alprostadil, respectively. Conclusion. The ability of alprostadil to inhibit myometrial relaxation induced by sevofl urane suggests that the use of alprostadil during general anesthesia for cesarean section may be advantageous for the reduction of postpartum bleeding.
sevofl urane-induced myometrial relaxation using myometrial strips isolated from pregnant rats.
Materials and methods
The protocol for this study was approved by the animal care and use committee at St. Marianna University School of Medicine. Two series of experiments were carried out. The fi rst experiment was designed to confi rm the induction of myometrial relaxation by sevofl urane and the second investigated the ability of alprostadil to inhibit sevofl urane-induced myometrial relaxation. A schematic of the experimental protocol is shown in Fig. 1 .
Tissue preparations
Sprague-Dawley rats (300-400 g) in the late stage of gestation (19-21 days) were anesthetized via intraperitoneal administration of pentobarbital and the uterus was excised. The excised uterus was bathed in a fl at container containing Krebs solution with the following composition (mM·l −1 ): NaCl 113, KCl 4.7, MgSO 4 ·7H 2 O 0.9, KH 2 PO 4 1.2, CaCl 2 ·2H 2 O 1.4, Glucose 11.5, NaHCO 3 25. The uterus was immediately dissected in the longitudinal direction from the mesometrium side and the fetuses and placentas were carefully removed. Longitudinal myometrial strips (approximately 5 × 10 mm) were made from the uterus. From one rat, four strips were taken and the average contraction was calculated. In some cases, however, only three strips were available for various technical reasons.
Measurements of myometrium contraction
The strips were positioned perpendicularly in organ baths, and the baths were fi lled with Krebs solution bubbled with 95% oxygen and 5% carbon dioxide at 37°C. One end of each strip was connected to the bottom of the organ bath and the other end was connected to a strain gauge transducer (LVS-50GA, Kyowa, Tokyo, Japan). The data from the transducer were recorded on a computer via an interface (PCD-300A, Kyowa, Tokyo, Japan). As an index of myometrium contraction, the amplitude was calculated as the average for the myometrium contractions in a 5-min period, while the frequency was determined by the number of myometrium contractions in a 5-min period. The area under the curve (AUC) of contractions over a 5-min period was calculated using specialized software developed for analyzing the data (PCD-30A, Kyowa, Tokyo, Japan).
The strips were allowed to equilibrate at resting tension (10 mN) for 60 min. During the last 5 min of equilibration, the baseline contraction data were measured and recorded.
Effect of time and sevofl urane on spontaneous myometrium contraction
In the fi rst experiment, designed to study the changes in spontaneous myometrium contraction over time, the strips remained in the organ bath for an additional 65 minutes following equilibration without the addition of any drug. The contractions were measured and recorded during the last 5 min (n = 8, experiment 1A).
The effect of sevofl urane on spontaneous myometrium contraction was studied using another eight strips. Following equilibration of the strips, sevofl urane 2% [approximately 1 minimum alveolar concentration (MAC)], was administered to the gas mix (95% oxygen and 5% carbon dioxide) for an additional 65 minutes. Contractions were measured during the last 5 min (n = 8, experiment 1B).
Inhibitory effect of alprostadil on sevofl urane-induced myometrial relaxation
To elucidate the inhibitory effect of alprostadil on sevofl urane-induced myometrial relaxation, alprostadil (Sigma-Aldrich, St. Louis, MO, USA) was titrated at three different concentrations. Myometrium contractions were measured while sevofl urane was continuously administered (n = 8).
After 60 min of tissue equilibration, baseline contraction values were measured and sevofl urane 2% was administered into the gas mix (95% oxygen and 5% carbon dioxide) and bubbled for 65 min continuously. Twenty fi ve minutes following the addition of sevofl urane, the control contraction data were measured for 5 min. Alprostadil was then titrated at 1 × 10 −8 g·ml −1 (low concentration), and immediately after the addition of alprostadil the contraction data were measured for 
